Rivaroxaban
Rivaroxaban is a new oral anticoagulant for adult patients with nonvalvular atrial fibrillation (except atrial fibrillation due to rheumatic valvular heart disease, and atrial fibrillation following heart valve replacement) to reduce the risk of stroke and systemic embolism
| Supplier | CD Formulation |
|---|---|
| Product # | PAP-0069 |
| Pricing | , Inquire for price |
| Solubility | insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL in DMSO with gentle warming |
| product1 | Cardiovascular Series |
| Storage | Inert atmosphere,2-8°C |
| Molecular Formula | C19H18ClN3O5S |
| Applications | Rivaroxaban is used primarily to treat venous thrombosis in adults |
| Boiling Point | 732.6±60.0 °C(Predicted) |
| Melting Point | 228-229°C |
| Density | 1.460±0.06 g/cm3(Predicted) |
| CAS Number | 366789-02-8 |
| Category | Cardiovascular |
| Appearance | Solid |
| Standard | EP |
| Grade | CEP/ISO |
| Physical State | solid |